Full Program

Monday 21 August

8.45–10.00	Plenary One: Sirius
8.45	Traditional Welcome / Opening: Mr Keith Wilson
9.00	K:1. Prof Richard Warner (US): Outcome from Schizophrenia throughout the Twentieth Century
10.00	Morning tea
10.30–12.30	Plenary Two: Sirius
10.30	Outcomes symposium O:01. Kulkarni, J. SCAP: A prospective study of outcomes in patients with schizophrenia. Part 1: Clinical Outcomes and Medication Use O:02. Montgomery, W. SCAP: A prospective study of outcomes in patients with schizophrenia. Part 2: The costs associated with schizophrenia in Australia O:03. Frost, A. Results from a multisite effectiveness evaluation of Early Psychosis treatment: Applying hierarchical linear modeling. O:04. Stain, H. The DEPTH project: A multisite RCT for youths at risk for psychosis O:05. Yung, A. Identifying Individuals At Ultra-High Risk Of Developing Psychosis O:06. Wilson, D. The Case for Dual Antipsychotic Use in Treatment Resistant Schizophrenia O:07. Ventouras, J. Social Rituals and Early Detection of Mental Illness O:08. Barton, K. Reducing symptoms of PTSD amongst carers of people with psychosis: a pilot study examining the impact of writing about caregiving experiences
12.30	Lunch
1.30	Coffee and Poster Session
2.00–3.00	Plenary Three: Sirius
2.00	K:2. Dr R Thara (India): Is the outcome of schizophrenia in the third world really better?
3.00	Afternoon tea
3.30–5.30	Concurrent Symposia
	Sirius	Pleiades	Rottnest Room (upstairs)
3.30	Animal models in schizophrenia(Chair: D Eyles) O:09. Eyles, D. Animal Models for Schizophrenia, Why do we Bother? O:10. Burne, T. Modeling cognitive deficits in schizophrenia using rodents O:11. Martin-Iverson, M. Prepulse Inhibition of the Startle Reflex in Patients Treated With Atypical Neuroleptics O:12. Chahl, L. The somatosensory system and schizophrenia O:13. Van den Buuse, M. Maternal deprivation and corticosterone administration in rats as a neurodevelopmental model of schizophrenia: effects on behaviour and dopamine receptor density O:14. Kesby, J. Developmental Vitamin D Depletion alters adult rat behaviour and response to psychomimetic drugs: a relevant model for schizophrenia O:15. DuBois, T. Brain development disruption from PCP causes behavioural deficits in the forced swim test in later life O:16. Karl, T. Genetic animal models for neuregulin 1 – valuable tools for schizophrenia research?	MMN and temporal processing in schizophrenia – the past, the present and the future(Chair: P Michie) O:17. Michie, PT. Evidence from MMN of temporal processing deficits in schizophrenia O:18. Matthews, N. Temporal processing in schizophrenia – evidence for impairment across a range of time scales O:19. Todd, J. Insensitivity to temporal context in schizophrenia O:20. Ward, PB. Mismatch negativity (MMN), executive function and symptom severity in 1st episode and chronic schizophrenia O:21. Schall, U. Spatiotemporal activation of MMN generators in schizophrenia O:22. Todd, JT. Between channel gap detection as a measure of left hemisphere advantage for temporal processing in the auditory system	Emotion, Social Cognition and Psychophysiology(Chair: C Loughland) O:23. Green, M. Social cognition in schizophrenia: Paying attention to context O:24. Langdon, R. Theory-of-mind impairment in schizophrenia: a domain-general difficulty with perspective-taking O:25. Das, P. Automated and controlled processing of fear facial expression display dysfunctions in the amygdala pathways in schizophrenia: a functional connectivity approach O:26. Loughland, C. Are visuo-cognitive disturbances in first-degree relatives of schizophrenia patients evidence for a vulnerability marker? O:27. Green, M. Emotion recognition training normalizes visual scan paths to faces in schizophrenia O:28. McCabe, K. Remediation of facial affect decoding and visual scanpath deficits in schizophrenia To be followed by 30 mins discussion time
5.30	Welcome drinks
6.00–7.30	Plenary Four: Sirius Movie Screening: Out of the Shadow Facilitator: Dr Norman Swan. Prof Assen Jablensky to take questions from the audience

Tuesday 22 August

8.45–10.00	Plenary Five: Sirius
8.45	Welcome: Dr Peter Wynn Owen
9.00	K:3. Prof Robin Murray (UK): Adolescent cannabis use and later psychosis
10.00	Morning tea
10.30–12.30	Plenary six: Sirius
10.30	Cannabis use and psychosis (Chair: David Castle) O:29. Cohen, M. Hits from the bong: An update on a functional imaging study of cannabis use and schizophrenia O:30. Solowij, N. Cannabis and cognition: Relevance to psychotic disorders O:31. Pawsey, B. Treating cannabis abuse in people with psychosis O:32. Lenton, S. Cannabis, health, and the law To be followed by 20 mins panel discussion including Prof R Murray and all symposium speakers
12.30	Lunch
1.30	Coffee and Poster Session
2.00	K:4. Prof David Nutt (UK): What we know, and what we don't know, about how treatments work in schizophrenia
3.00	Afternoon tea
3.30–5.30	Concurrent Symposia
	Sirius	Pleiades	Rottnest Room (upstairs)
3.30	Issues in Service Provision	Neuroimaging	Neurochemistry
	K:5. Prof David Castle (Aust). Australian mental Health Service reforms: the good, the bad and the way forward	O:37. Tripathi, B. Cognitive functions and metabolite changes in frontal lobe and in thalamus of first onset schizophrenic patients using proton MRS O:38. Whitford, T. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal MRI study O:39. Wood, S. Hippocampal Volume and MR Spectroscopy in Early sychosis: A Cross-Sectional Comparison of Neuroleptic-Naive and Early-Treated Patients O:40. Harris, A. Longitudinal changes in regional grey matter volume and corresponding EEG power in first-episode psychosis O:41. Yücel, M. Challenging dorsal anterior cingulate hypofunction in schizophrenia: An fMRI study of cognitive conflict O:42. Sergejew, A. Auditory Hallucinations in Psychosis: altered cortical connectivity and “release” in neural substrates of episodic verbal memory and central auditory processing O:43. Loo, C. Trancranial Magnetic Stimulation – A Novel Treatment for Auditory Hallucinations in Schizophrenia?	O:44. Dean, B. Changed kainate receptors in the Brodmann's area 9 from subjects with schizophenia O:45. Scarr, E. M1/M4 receptor expression in the hippocampus from subjects with schizophrenia O:46. Sivagnanasundaram, S. Proteome analysis of the corpus callosum of schizophrenia O:47. Poa, N. Atypical antipsychotics associated with insulin resistance in New Zealand Maori O:48. Hinton, T. Antipsychotic drug effects on GABAA receptors O:49. Tripathi, B. Neurochemical changes in frontal and temporal lobe of schizophrenic patients on conventional antipsychotic and clozapine treatment
4.30	Neurodevelopment O:33. Morgan, V. Is the risk of intellectual disability, rare syndromes or epilepsy elevated in the children of women with a psychotic illness? Results from a Western Australian population-based cohort study O:34. Welham, J. Lifetime prevalence of psychosis by age 21 in an Australian birth cohort O:35. Campbell, L. Cognition and Brain in Children with 22q11.2 Deletion Syndrome O:36. Campbell, L. Brain and Behaviour in Children with 22q11.2 Deletion Syndrome: A Volumetric and Voxel-Based Morphometry MRI Study
5.30	Close of day sessions
7.00–7.30	Pre-dinner drinks and Tour of the WA Maritime Museum, Victoria Quay, Fremantle
7.30	WA Maritime Museum Dinner-Debate Debate topic: Is schizophrenia a scientific delusion? Moderated by Dr Norman Swan

Wednesday 23 August

8.45–10.00	Plenary seven: Sirius
8.45	Welcome Presentation of UWA School of Psychiatry and Clinical Neurosciences Travel Awards. Professor A Janca, Head of School Introducing the Schizophrenia International Research Society (SIRS). Prof John McGrath
9.00	K:6. Prof Assen Jablensky (Aust.): The neuroscience of schizophrenia
10.00	Morning tea
10.30–12.30	Plenary eight: Sirius
10.30	K:7. Prof Cam Carter (US). Understanding cognition in schizophrenia: control, disorganization and the frontal cortex
11.30	First episode psychosis and early intervention symposium and discussion K:8. Prof Richard Warner: Early intervention in psychosis: A Critique. K:9. Prof Patrick McGorry (Aust.): Early intervention in psychosis K:10. Dr Thara (India). How critical is early intervention for psychoses in developing countries?
12.30	Lunch
1.30	Coffee and Poster Session
2.00–4.00	Concurrent Symposia
	Sirius	Pleiades	Rottnest Room (upstairs)
2.00	Neurocognition O:50. Eadie, K. Cognitive Deficits, Length of Illness & Symptom Severity in Schizophrenia O:51. Byrne, L. Preserved versus compromised intellectual functioning in first-episode psychosis: patterns of cognitive functioning and stability over time O:52. Dragovic, M. Personality traits in genetically distinct groups of schizophrenia patients and their relatives O:53. Asgari, F. Source Monitoring and Auditory Hallucinations in Clinical and Non-clinical Samples O:54. Bendall, E. Normal and Anomalous Classification of Category Exemplars in Schizophrenia O:55. Waters, F. Cognitive mechanisms of depression in schizophrenia O:56. Menon, K. The SRM as an Explanatory Model in Schizophrenia	Molecular genetics and schizophrenia O:57. Schwab, SG. Analysis of linkage disequilibrium with schizophrenia in three candidate genes: GRM-3, AKT-1 and NRG-1 O:58. Morar, B. Evaluation of linkage disequilibrium in the TNF alpha gene region on chromosome 6p in families with schizophrenia O:59. Ludewick, H. The presence of alternatively spliced variants and the relative expression of dysbindin in lymphoblast cell lines of schizophrenic patients O:60. Behravan, J. Lack of association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population O:61. Tooney, P. Dysfunction of genes regulating membrane exocytosis in schizophrenia O:62. Khademy-Deljo, A. Investigation of associations between Single Nucleotide Polymorphisms (SNP) of the Muscarinic1 Receptor (M1R) gene and cognitive deficits in schizophrenia O:63. Edgar, P. Violent Behaviour Associated with a Novel ApoB Gene Mutation (apoB-29.4), which causes Hypocholesterolemia O:64. Chetcuti, A. Molecular mechanisms of Lithium Chloride: What can mice teach us about Bipolar Disorder?	Psychopathology O:65. Langdon, R. Jumping to delusions in early psychosis O:66. Startup, M. Referential delusions of communication and self-monitoring deficits in psychosis O:67. Cosgrave, A. Psychotic-Like Experiences in Non-Psychotic Help-Seekers: Associations with distress, depression and disability O:68. Beckmann, CJ. Dissociative Experiences And Transition To Psychosis O:69. Beckmann, CJ. Course and outcome of psychosis in the East Kimberley
Free Communications O:70. McCauley, K. You can't have a baby – you have schizophrenia O:71. Walsh, D. Creative Expression Centre For Arts Therapy And Reflections Art Studio: Two Unique Art Therapy Mental Health Recovery Programs (30 mins)
4.00	Close of Conference